Bespoke Extracts (BSPK) Financials
Newest figures come from the 10-Q for Q3 FY2025, filed Nov 12, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BSPK SEC filings page.
Bespoke Extracts Inc (BSPK) reported $1.1M in revenue for fiscal year 2024, up 42.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Revenue has expanded, yet overhead and capital demands still outpace cash generation while liabilities exceed the asset base by a wide margin.
The business is not yet converting gross profit into operating earnings: in FY2024, gross margin fell from43.7% to40.5% . That compression coincided with SG&A consuming114.5% of revenue, leaving operating margin at-89.0% .
Cash conversion is weak: FY2024 operating cash flow was negative
The balance sheet is structurally strained: total liabilities were
Financial Health Signals
We do not publish a peer-relative financial health score for Bespoke Extracts Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Bespoke Extracts Inc scores -112.16, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $26.4M against total assets of $359K. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Bespoke Extracts Inc passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.
Bespoke Extracts Inc reported a net loss of $1.0M while operations used $290K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Bespoke Extracts Inc reported an operating loss of $995K against $60K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Bespoke Extracts Inc generated $468K in revenue in Q3 2025. This represents an increase of 68.6% from the same quarter a year earlier. Against the prior quarter it is up 19.8%.
Bespoke Extracts Inc's EBITDA was -$51K in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Bespoke Extracts Inc reported a net loss of $78K in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Bespoke Extracts Inc earned -$0.01 per diluted share (EPS) in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Bespoke Extracts Inc recorded an outflow of $20K in free cash flow in Q3 2025, representing a cash shortfall after capex. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Bespoke Extracts Inc held $17K in cash as of Q3 2025; no long-term debt figure is on record for that period.
Not reported for Q3 2025.
Margins & Returns
Bespoke Extracts Inc's gross margin was 50.0% in Q3 2025, indicating the percentage of revenue retained after direct costs. This is up 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.5 percentage points.
Bespoke Extracts Inc's operating margin was -11.5% in Q3 2025, reflecting core business profitability. This is up 83.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 29.9 percentage points.
Bespoke Extracts Inc's net profit margin was -16.7% in Q3 2025, showing the share of revenue converted to profit. This is up 82.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 35.8 percentage points.
Not reported for Q3 2025.
Capital Allocation
Bespoke Extracts Inc reported no capital expenditure in Q3 2025. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2025.
Not reported for Q3 2025.
BSPK Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Revenue | $468K+68.6% | $391K+40.4% | $263K+1.0% | $301K+14.3% | $277K+13.5% | $278K+47.8% | $260K+192.6% | $264K |
| Cost of Revenue | $234K+43.9% | $193K+12.2% | $152K-3.5% | $172K+71.4% | $162K+11.3% | $172K+46.8% | $158K+100.7% | $100K |
| Gross Profit | $234K+103.6% | $197K+86.1% | $111K+8.0% | $129K-20.9% | $115K+16.9% | $106K+49.4% | $103K+891.2% | $163K+251.9% |
| SG&A Expenses | $260K-28.0% | $338K+3.6% | $313K-10.0% | $244K-40.0% | $361K+3.9% | $326K-28.7% | $348K-7.1% | $407K |
| Operating Income | -$54Kn/m | -$162Kn/m | -$245Kn/m | -$179Kn/m | -$262Kn/m | -$250Kn/m | -$303Kn/m | -$265K |
| EBITDA | -$51Kn/m | -$160Kn/m | -$244Kn/m | -$177Kn/m | -$260Kn/m | -$248Kn/m | -$299Kn/m | -$313K |
| Interest Expense | $4K-67.9% | $4K-60.3% | N/A | $25K+129.7% | $13K+146.3% | $11Kn/m | $11Kn/m | $11K |
| Net Income | -$78Kn/m | -$205Kn/m | -$261Kn/m | -$187Kn/m | -$276Kn/m | -$261Kn/m | -$314Kn/m | -$276K |
| EPS (Basic) | -$0.01n/m | -$0.02n/m | -$0.02n/m | -$0.02 | -$0.03n/m | -$0.03n/m | -$0.03n/m | -$0.03n/m |
| EPS (Diluted) | -$0.01n/m | -$0.02n/m | -$0.02n/m | -$0.02 | -$0.03n/m | -$0.03n/m | -$0.03n/m | -$0.10n/m |
| Diluted Shares (Avg) | 11M+5.8% | 11M+9.7% | 11M+9.7% | N/A | 11M+4.6% | 10M0.0% | 10M+0.6% | N/A |
Not reported in any period shown, so not listed: R&D Expenses, Income Tax.
BSPK Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $296K-12.6% | $267K-27.3% | $248K-30.3% | $359K+1.3% | $338K-12.9% | $367K-18.0% | $356K-25.6% | $354K-13.5% |
| Current Assets | $197K+58.7% | $155K+15.9% | $123K+18.6% | $165K+101.9% | $124K+27.9% | $134K-3.1% | $104K-30.3% | $82K-26.8% |
| Cash & Equivalents | $17K-21.9% | $1K-94.5% | $30K+110.6% | $60K+812.7% | $21K | $25K+1173.3% | $14K+230.3% | $7K-73.0% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0n/m | $0n/m | $0n/m |
| Inventory | $64K+43.9% | $42K+29.1% | $39K+0.1% | $33K+105.9% | $44K+73.1% | $32K-23.7% | $39K+198.8% | $16Kn/m |
| Accounts Receivable | $104K+124.7% | $101K+70.7% | $37K-14.8% | $57K+26.6% | $46K+0.3% | $59K+39.9% | $43K-7.2% | $45K |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0 | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $2.9M+8.4% | $2.8M+10.5% | $2.6M+10.9% | $2.5M+17.9% | $2.7M+37.4% | $2.5M+41.8% | $2.3M+60.7% | $2.1M+92.2% |
| Current Liabilities | $1.9M+8.4% | $1.5M-5.6% | $1.2M-7.7% | $1.1M+3.7% | $1.7M+86.7% | $1.6M+107.6% | $1.3M+7.7% | $1.1M+24.6% |
| Non-Current Liabilities | $1.0M+8.4% | $1.3M+36.7% | $1.3M+36.4% | $1.3M+33.2% | $940K-7.6% | $966K-6.5% | $983K+391.8% | $1000K+362.9% |
| Total Equity | -$2.6Mn/m | -$2.5Mn/m | -$2.3Mn/m | -$2.1Mn/m | -$2.3Mn/m | -$2.2Mn/m | -$2.0Mn/m | -$1.7Mn/m |
| Retained Earnings | -$26.9Mn/m | -$26.9Mn/m | -$26.7Mn/m | -$26.4Mn/m | -$26.2Mn/m | -$25.9Mn/m | -$25.7Mn/m | -$25.4Mn/m |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
BSPK Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$20Kn/m | -$31Kn/m | -$73Kn/m | -$136Kn/m | -$28K-504.4% | -$28Kn/m | -$97Kn/m | -$20Kn/m |
| Depreciation & Amortization | $3K+16.6% | $2K+25.7% | $2K-48.3% | $3K+46.6% | $3K-86.4% | $2K-89.9% | $3K-81.0% | $2K |
| Stock-Based Compensation | N/A | N/A | $3K-94.1% | N/A | N/A | N/A | $50K-45.5% | N/A |
| Capital Expenditures | $0 | $0 | $600K | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$20K | -$31K | -$673K | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $35K+40.0% | $2K-94.8% | $43K-59.0% | $175K+563.5% | $25Kn/m | $39K-80.0% | $105K-43.9% | $26K-89.7% |
Not reported in any period shown, so not listed: Investing Cash Flow, Dividends Paid, Share Buybacks.
BSPK Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'25Filing | Q1'25Filing | Q4'24Filing | Q3'2410-Q | Q2'24Filing | Q1'24Filing | Q4'23Filing |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 50.0%+8.6pp | 50.6%+12.4pp | 42.1%+2.7pp | 42.9%-19.0pp | 41.4%+1.2pp | 38.1%+0.4pp | 39.4%+27.8pp | 61.9% |
| Operating Margin | -11.5%+83.1pp | -41.5%+48.5pp | -93.2% | -59.4% | -94.6% | -90.0% | -116.3% | -100.4% |
| Net Margin | -16.7%+82.6pp | -52.5%+41.3pp | -99.0% | -62.0% | -99.3% | -93.8% | -120.6% | -104.6% |
| Return on Assets | -26.4%+55.1pp | -76.8%-5.8pp | -105.0%-16.7pp | -52.0%+25.8pp | -81.5%-3.8pp | -71.0%+32.7pp | -88.3%+3.8pp | -77.8% |
| Current Ratio | 0.110.0x | 0.100.0x | 0.100.0x | 0.15+0.1x | 0.070.0x | 0.08-0.1x | 0.080.0x | 0.08-0.1x |
| Asset Turnover | 1.58+0.8x | 1.46+0.7x | 1.06+0.3x | 0.84+0.1x | 0.82+0.2x | 0.76+0.3x | 0.73+0.5x | 0.74 |
| FCF Margin | -4.2% | -7.9% | -255.7% | N/A | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Note: Shareholder equity is negative (-$2.1M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.15), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Bespoke Extracts Inc BSPK | FY2024 | $1.1M | -$1.0M | -92.8% | $6K | — |
| One World Products Inc OWPC | FY2024 | $5K | N/A | N/A | $36K | — |
Where Bespoke Extracts Inc Ranks
Frequently Asked Questions
Bespoke Extracts Inc (BSPK) reported $1.1M in total revenue for fiscal year 2024. This represents a 42.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Bespoke Extracts Inc (BSPK) revenue grew by 42.3% year-over-year, from $785K to $1.1M in fiscal year 2024.
No, Bespoke Extracts Inc (BSPK) reported a net loss of $1.0M in fiscal year 2024, with a net profit margin of -92.8%.
Bespoke Extracts Inc (BSPK) had EBITDA of -$985K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
Bespoke Extracts Inc (BSPK) had a gross margin of 40.5% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
Bespoke Extracts Inc (BSPK) had an operating margin of -89.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
Bespoke Extracts Inc (BSPK) had a net profit margin of -92.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Bespoke Extracts Inc (BSPK) recorded an outflow of $890K in free cash flow during fiscal year 2024. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Bespoke Extracts Inc (BSPK) recorded an outflow of $290K in operating cash flow during fiscal year 2024, representing cash used by core business activities.
Bespoke Extracts Inc (BSPK) had $359K in total assets as of fiscal year 2024, including both current and long-term assets.
Bespoke Extracts Inc (BSPK) invested $600K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Bespoke Extracts Inc (BSPK) had a current ratio of 0.15 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
Bespoke Extracts Inc (BSPK) had a return on assets of -288.9% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
At the end of fiscal year 2024, Bespoke Extracts Inc (BSPK) held $60K in cash, cash equivalents and investments, and reported an operating cash outflow of $290K over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Bespoke Extracts Inc (BSPK) has negative shareholder equity of -$2.1M as of fiscal year 2024, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Bespoke Extracts Inc (BSPK) has an Altman Z-Score of -112.16, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Bespoke Extracts Inc (BSPK) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Bespoke Extracts Inc (BSPK) reported a net loss of $1.0M while operations used $290K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Bespoke Extracts Inc (BSPK) reported an operating loss of $995K against $60K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.